MYH9 and hepatocellular carcinoma: MYH9 can also interact with GSK3β and facilitate GSK3β ubiquitination and degradation to favor cancer stemness properties in hepatocellular carcinoma [51], illustrating that KRT19/MYH9 may coordinate cell fate specification via orchestrating regulatory hubs with GSK3β.